Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. NVDA
6. IBM
7. PRIM
8. SPY
9. ACN
10. BLZE

Go back to Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
COGENT (NASDAQ: COGT) Delayed: 36.36 +0.52 (1.45%)
Previous Close $35.84    52 Week High $5.57 
Open $35.40    52 Week Low $2.90 
Day High $36.90    P/E 165.27 
Day Low $34.70    EPS $0.22 
Volume 2,708,284